Moderna Announces Update To 2022 Supply Agreement With Gavi That Secures Access To Updated Variant-Specific COVID-19 Vaccines For Low-and-Middle Income Countries
Given the sufficient supply of COVID-19 vaccines globally, Moderna & Gavi have mutually agreed to cancel remaining pending orders under the current COVID-19 vaccine supply agreement for 2022
Gavi and Moderna have
